License system for toll manufacturing medicines triggers debate

Published: 2010-11-30 07:00:00

Updated: 2010-11-30 07:00:00

The government has approved the license of locally produced drugs by toll manufacturing, when an applicant without GMP facilities intends to make an application of new drugs which have not been available in Korea.

The Korea Food and Drug Administration said the system may ensure the distributi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK